Bio-Rad Laboratories, Inc. - stock earnings
BIO Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 AfterMarket | - / 2.0400000000 | - | - / 619.1 million | - |
BIO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 349.7 million USD | 681.2 million USD |
| 2023Q3 | 106.3 million USD | 632.1 million USD |
| 2023Q2 | -1.2 billion USD | 681.1 million USD |
| 2023Q1 | 69.0 million USD | 676.8 million USD |
| 2022Q4 | 833.5 million USD | 730.3 million USD |
| 2022Q3 | -164.2 million USD | 680.8 million USD |
| 2022Q2 | -927.2 million USD | 691.1 million USD |
| 2022Q1 | -3.4 billion USD | 700.1 million USD |
| 2021Q4 | -1.6 billion USD | 732.8 million USD |
| 2021Q3 | 3.9 billion USD | 747.0 million USD |
| 2021Q2 | 914.1 million USD | 715.9 million USD |
| 2021Q1 | 977.4 million USD | 726.8 million USD |
| 2020Q4 | 839.1 million USD | 789.8 million USD |
| 2020Q3 | 1.3 billion USD | 647.3 million USD |
| 2020Q2 | 966.4 million USD | 536.9 million USD |
| 2020Q1 | 685.9 million USD | 571.6 million USD |
| 2019Q4 | 553.5 million USD | 624.4 million USD |
| 2019Q3 | -258.8 million USD | 560.6 million USD |
| 2019Q2 | 598.8 million USD | 572.6 million USD |
| 2019Q1 | -833.1 million USD | 617.5 million USD |
| 2018Q4 | -828.5 million USD | 616.8 million USD |
| 2018Q3 | 269.3 million USD | 545.1 million USD |
| 2018Q2 | 268.0 million USD | 575.9 million USD |
| 2018Q1 | 69.9 million USD | 620.4 million USD |
| 2017Q4 | 77.4 million USD | 620.4 million USD |
| 2017Q3 | 27.4 million USD | 535.0 million USD |
| 2017Q2 | 5.0 million USD | 504.7 million USD |
| 2017Q1 | 12.4 million USD | 500.1 million USD |
| 2016Q4 | -20.6 million USD | 571.5 million USD |
| 2016Q3 | 18.4 million USD | 508.7 million USD |
| 2016Q2 | 18.0 million USD | 516.8 million USD |
| 2016Q1 | 12.3 million USD | 471.2 million USD |
| 2015Q4 | 49.5 million USD | 570.6 million USD |
| 2015Q3 | 17.4 million USD | 470.0 million USD |
| 2015Q2 | 28.4 million USD | 506.1 million USD |
| 2015Q1 | 17.8 million USD | 472.8 million USD |
| 2014Q4 | 39.0 million USD | 598.2 million USD |
| 2014Q3 | 11.5 million USD | 530.6 million USD |
| 2014Q2 | 31.6 million USD | 536.8 million USD |
| 2014Q1 | 6.7 million USD | 509.3 million USD |
| 2013Q4 | 30.1 million USD | 602.6 million USD |
| 2013Q3 | -7.1 million USD | 505.1 million USD |
| 2013Q2 | 34.7 million USD | 525.3 million USD |
| 2013Q1 | 19.5 million USD | 499.7 million USD |
| 2012Q4 | 47.5 million USD | 573.8 million USD |
| 2012Q3 | 42.4 million USD | 498.7 million USD |
| 2012Q2 | 48.3 million USD | 510.4 million USD |
| 2012Q1 | 31.0 million USD | 486.3 million USD |
| 2011Q4 | 59.2 million USD | 550.2 million USD |
| 2011Q3 | 45.9 million USD | 516.5 million USD |
| 2011Q2 | 40.0 million USD | 521.7 million USD |
| 2011Q1 | 33.0 million USD | 485.1 million USD |
| 2010Q4 | 67.9 million USD | 533.7 million USD |
| 2010Q3 | 44.8 million USD | 471.5 million USD |
| 2010Q2 | 38.0 million USD | 467.7 million USD |
| 2010Q1 | 34.9 million USD | 454.2 million USD |
| 2009Q4 | 37.9 million USD | 495.1 million USD |
| 2009Q3 | 38.5 million USD | 461.1 million USD |
| 2009Q2 | 38.0 million USD | 427.2 million USD |
| 2009Q1 | 30.3 million USD | 400.9 million USD |
| 2008Q4 | -8.2 million USD | 448.0 million USD |
| 2008Q3 | 27.8 million USD | 441.8 million USD |
| 2008Q2 | 43.4 million USD | 452.4 million USD |
| 2008Q1 | 26.5 million USD | 422.2 million USD |
| 2007Q4 | 12.4 million USD | 459.7 million USD |
| 2007Q3 | 28.0 million USD | 339.7 million USD |
| 2007Q2 | 25.7 million USD | 339.1 million USD |
| 2007Q1 | 27.0 million USD | 322.5 million USD |
| 2006Q4 | 16.6 million USD | 343.1 million USD |
| 2006Q3 | 23.2 million USD | 304.8 million USD |
| 2006Q2 | 32.3 million USD | 317.7 million USD |
| 2006Q1 | 31.2 million USD | 308.3 million USD |
| 2005Q4 | 13.5 million USD | 307.3 million USD |
| 2005Q3 | 16.2 million USD | 283.2 million USD |
| 2005Q2 | 18.4 million USD | 291.3 million USD |
| 2005Q1 | 33.5 million USD | 299.2 million USD |
| 2004Q4 | 17.1 million USD | 307.9 million USD |
| 2004Q3 | 6.3 million USD | 258.8 million USD |
| 2004Q2 | 22.9 million USD | 260.5 million USD |
| 2004Q1 | 22.0 million USD | 266.6 million USD |
| 2003Q4 | 19.2 million USD | 266.2 million USD |
| 2003Q3 | 9.7 million USD | 247.7 million USD |
| 2003Q2 | 21.0 million USD | 243.5 million USD |
| 2003Q1 | 26.4 million USD | 246.0 million USD |
| 2002Q4 | 16.2 million USD | 243.0 million USD |
| 2002Q3 | 16.6 million USD | 224.9 million USD |
| 2002Q2 | 16.2 million USD | 214.7 million USD |
| 2002Q1 | 18.8 million USD | 210.2 million USD |
| 2001Q4 | 17.0 million USD | 233.4 million USD |
| 2001Q3 | 7.0 million USD | 186.1 million USD |
| 2001Q2 | 11.6 million USD | 195.4 million USD |
| 2001Q1 | 8.6 million USD | 202.7 million USD |
| 2000Q4 | 9.2 million USD | 183.0 million USD |
| 2000Q3 | 13.9 million USD | 174.1 million USD |
| 2000Q2 | 5.1 million USD | 185.1 million USD |
| 2000Q1 | 3.0 million USD | 183.7 million USD |
| 1999Q4 | -11.2 million USD | 194.4 million USD |
| 1999Q3 | 4.3 million USD | 113.5 million USD |
| 1999Q2 | 7.9 million USD | 115.8 million USD |
| 1999Q1 | 10.8 million USD | 125.7 million USD |
| 1998Q4 | 6.4 million USD | 118.8 million USD |
| 1998Q3 | 1.9 million USD | 99.0 million USD |
| 1998Q2 | 7.2 million USD | 107.9 million USD |
| 1998Q1 | 8.8 million USD | 116.2 million USD |
| 1997Q4 | 1.4 million USD | 115.8 million USD |
| 1997Q3 | 2.6 million USD | 99.5 million USD |
| 1997Q2 | 4.9 million USD | 105.8 million USD |
| 1997Q1 | 7.5 million USD | 105.9 million USD |
| 1996Q4 | 2.5 million USD | 114.0 million USD |
| 1996Q3 | 6.7 million USD | 96.6 million USD |
| 1996Q2 | 7.5 million USD | 100.0 million USD |
| 1996Q1 | 9.5 million USD | 108.3 million USD |
| 1995Q4 | 6.2 million USD | 107.9 million USD |
| 1995Q3 | 4.4 million USD | 92.9 million USD |
| 1995Q2 | 6.5 million USD | 97.9 million USD |
| 1995Q1 | 8.1 million USD | 97.9 million USD |
| 1994Q4 | 4.2 million USD | 96.7 million USD |
| 1994Q3 | 3.9 million USD | 83.8 million USD |
| 1994Q2 | 2.8 million USD | 85.1 million USD |
| 1994Q1 | 4.7 million USD | 89.7 million USD |
| 1993Q4 | -800000 USD | 87.3 million USD |
| 1993Q3 | 100000 USD | 78.9 million USD |
| 1993Q2 | 200000 USD | 81.8 million USD |
| 1993Q1 | 3.2 million USD | 80.5 million USD |
| 1992Q4 | 1.4 million USD | 88.1 million USD |
| 1992Q3 | 2.2 million USD | 78.6 million USD |
| 1992Q2 | 8.5 million USD | 80.0 million USD |
| 1992Q1 | 3.5 million USD | 83.6 million USD |
| 1991Q4 | 1.5 million USD | 82.4 million USD |
| 1991Q3 | 1.7 million USD | 75.1 million USD |
| 1991Q2 | 1.4 million USD | 76.5 million USD |
| 1991Q1 | 3.6 million USD | 76.7 million USD |
| 1990Q4 | 3.4 million USD | 80.3 million USD |
| 1990Q3 | 1.6 million USD | 69.5 million USD |
| 1990Q2 | 2.1 million USD | 68.8 million USD |
| 1990Q1 | 3.6 million USD | 68.1 million USD |
| 1989Q4 | 2.8 million USD | 64.8 million USD |
| 1989Q3 | 1.4 million USD | 55.1 million USD |
| 1989Q2 | 2.7 million USD | 60.0 million USD |
| 1989Q1 | ? USD | 56.3 million USD |
| 1988Q4 | ? USD | 53.3 million USD |
| 1988Q3 | ? USD | 46.2 million USD |
| 1988Q2 | ? USD | 49.0 million USD |
| 1988Q1 | ? USD | 50.5 million USD |
| 1987Q4 | ? USD | 44.1 million USD |
| 1987Q3 | ? USD | 39.0 million USD |
| 1987Q2 | ? USD | 38.9 million USD |
| 1987Q1 | ? USD | 37.5 million USD |
| 1986Q4 | ? USD | 34.0 million USD |
| 1986Q3 | ? USD | 31.1 million USD |
| 1986Q2 | ? USD | 31.4 million USD |
| 1986Q1 | ? USD | 30.0 million USD |
| 1985Q4 | ? USD | 27.2 million USD |
| 1985Q3 | ? USD | 25.4 million USD |
BIO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -637.3 million USD | 2.7 billion USD |
| 2022 | -3.6 billion USD | 2.8 billion USD |
| 2021 | 4.3 billion USD | 2.9 billion USD |
| 2020 | 3.8 billion USD | 2.5 billion USD |
| 2019 | 1.8 billion USD | 2.3 billion USD |
| 2018 | 361.0 million USD | 2.3 billion USD |
| 2017 | 114.7 million USD | 2.2 billion USD |
| 2016 | 28.1 million USD | 2.1 billion USD |
| 2015 | 113.1 million USD | 2.0 billion USD |
| 2014 | 88.8 million USD | 2.2 billion USD |
| 2013 | 77.8 million USD | 2.1 billion USD |
| 2012 | 169.2 million USD | 2.1 billion USD |
| 2011 | 178.2 million USD | 2.1 billion USD |
| 2010 | 185.5 million USD | 1.9 billion USD |
| 2009 | 144.6 million USD | 1.8 billion USD |
| 2008 | 89.5 million USD | 1.8 billion USD |
| 2007 | 93.0 million USD | 1.5 billion USD |
| 2006 | 103.3 million USD | 1.3 billion USD |
| 2005 | 81.6 million USD | 1.2 billion USD |
| 2004 | 68.2 million USD | 1.1 billion USD |
| 2003 | 76.2 million USD | 1.0 billion USD |
| 2002 | 67.9 million USD | 892.7 million USD |
| 2001 | 44.2 million USD | 817.5 million USD |
| 2000 | 31.1 million USD | 725.9 million USD |
| 1999 | 11.7 million USD | 549.5 million USD |
| 1998 | 24.3 million USD | 441.9 million USD |
| 1997 | 16.4 million USD | 426.9 million USD |
| 1996 | 26.2 million USD | 418.8 million USD |
| 1995 | 25.2 million USD | 396.6 million USD |
| 1994 | 15.6 million USD | 355.3 million USD |
| 1993 | 2.8 million USD | 328.6 million USD |
| 1992 | 15.6 million USD | 330.3 million USD |
| 1991 | 8.2 million USD | 310.7 million USD |
| 1990 | 10.7 million USD | 286.7 million USD |
| 1989 | 10.1 million USD | 236.3 million USD |
| 1988 | 9.5 million USD | 198.9 million USD |
| 1987 | 7.7 million USD | 159.5 million USD |
| 1986 | 6.1 million USD | 126.6 million USD |
| 1985 | 4.3 million USD | 102.3 million USD |
BIO
Price: $274.06
52 week price:
Earnings Per Share: -21.81 USD
P/E Ratio: -54.70
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 92800
Ebitda: 79.8 millionMarket Capitalization: 8.8 billion